Pasar al contenido principal

LOS MACROFAGOS PRO-FIBRINOLITICOS, UN TIPO CELULAR CLAVE PARA LA REGRESION DE LA FIBROSIS EN LA ENFERMEDAD DEL HIGADO GRASO NO ALCOHOLICO

PID2021-125195OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease

  • Martínez-Sánchez, Celia
  • Bassegoda, Octavi|||0000-0002-6036-6026
  • Deng, Hongping
  • Almodóvar, Xènia
  • Ibarzabal, Ainitze|||0000-0002-1220-6474
  • de Hollanda, Ana|||0000-0001-9114-8614
  • Martínez García de la Torre, Raquel-Adela
  • Blaya, Delia
  • Ariño, Silvia
  • Jiménez-Esquivel, Natalia
  • Aguilar-Bravo, Beatriz
  • Vallverdú, Julia
  • Montironi, Carla|||0000-0002-1453-2193
  • Osorio-Conles, Oscar
  • Fundora Suarez, Yiliam|||0000-0003-4950-6988
  • Sánchez Moreno, Francisco Javier
  • Gómez-Valadés, Alicia G.
  • Aguilar-Corominas, Laia
  • Soria, Anna|||0000-0001-5671-8343
  • Pose, Elisa|||0000-0002-0224-7686
  • Juanola, Adrià|||0000-0003-4832-5130
  • Cervera, Marta
  • Perez, Martina
  • Hernández-Gea, Virginia|||0000-0001-7937-984X
  • Affò, Silvia
  • Swanson, Kelly S.
  • Ferrer-Fàbrega, Joana
  • Balibrea Del Castillo, José María|||0000-0002-0764-7179
  • Sancho-Bru, Pau|||0000-0001-5569-9259
  • Vidal, Josep|||0000-0002-4564-4518
  • Ginès, Pere|||0000-0003-4657-4504
  • Smith, Andrew M.
  • Graupera, Isabel|||0000-0001-9170-9784
  • Coll, Mar|||0000-0003-3726-0087
: The accumulation of adipose tissue macrophages (ATMs) in obesity has been associated with hepatic injury. However, the contribution of ATMs to hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD) remains to be elucidated. Herein, we investigate the relationship between ATMs and liver fibrosis in patients with patients with NAFLD and evaluate the impact of modulation of ATMs over hepatic fibrosis in an experimental non-alcoholic steatohepatitis (NASH) model. Adipose tissue and liver biopsies from 42 patients with NAFLD with different fibrosis stages were collected. ATMs were characterised by immunohistochemistry and flow cytometry and the correlation between ATMs and liver fibrosis stages was assessed. Selective modulation of the ATM phenotype was achieved by i.p. administration of dextran coupled with dexamethasone in diet-induced obesity and NASH murine models. Chronic administration effects were evaluated by histology and gene expression analysis in adipose tissue and liver samples. In vitro crosstalk between human ATMs and hepatic stellate cells (HSCs) and liver spheroids was performed. Patients with NAFLD presented an increased accumulation of pro-inflammatory ATMs that correlated with hepatic fibrosis. Long-term modulation of ATMs significantly reduced pro-inflammatory phenotype and ameliorated adipose tissue inflammation. Moreover, ATMs modulation was associated with an improvement in steatosis and hepatic inflammation and significantly reduced fibrosis progression in an experimental NASH model. In vitro, the reduction of the pro-inflammatory phenotype of human ATMs with dextran-dexamethasone treatment reduced the secretion of inflammatory chemokines and directly attenuated the pro-fibrogenic response in HSCs and liver spheroids. Pro-inflammatory ATMs increase in parallel with fibrosis degree in patients with NAFLD and their modulation in an experimental NASH model improves liver fibrosis, uncovering the potential of ATMs as a therapeutic target to mitigate liver fibrosis in NAFLD. We report that human adipose tissue pro-inflammatory macrophages correlate with hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD). Furthermore, the modulation of adipose tissue macrophages (ATMs) by dextran-nanocarrier conjugated with dexamethasone shifts the pro-inflammatory phenotype of ATMs to an anti-inflammatory phenotype in an experimental murine model of non-alcoholic steatohepatitis. This shift ameliorates adipose tissue inflammation, hepatic inflammation, and fibrosis. Our results highlight the relevance of adipose tissue in NAFLD pathophysiology and unveil ATMs as a potential target for NAFLD.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ductular reaction-associated neutrophils promote biliary epithelium proliferation in chronic liver disease

  • Ariño, Silvia
  • Aguilar-Bravo, Beatriz
  • Coll, Mar
  • Lee, Woo-Yong
  • Peiseler, Moritz
  • Cantallops-Vilà, Paula
  • Sererols-Viñas, Laura
  • Martínez-García de la Torre, Raquel A.
  • Martínez-Sánchez, Celia
  • Pedragosa, Jordi
  • Zanatto, Laura
  • Gratacós-Ginès, Jordi
  • Pose, Elisa
  • Blaya, Delia
  • Almodóvar, Xènia
  • Fernández-Fernández, María
  • Ruiz-Blázquez, Paloma
  • Lozano, Juan José
  • Affo, Silvia
  • Planas, Anna M.
  • Ginès, Pere
  • Moles, Anna
  • Kubes, Paul
  • Sancho-Bru, Pau
Background & Aims: Ductular reaction expansion is associated with poor prognosis in patients with advanced liver disease. However, the mechanisms promoting biliary cell proliferation are largely unknown. Here, we identify neutrophils as drivers of biliary cell proliferation and the defective wound-healing response. Methods: The intrahepatic localization of neutrophils was evaluated in patients with chronic liver disease. Neutrophil dynamics were analyzed by intravital microscopy and neutrophil-labeling assays in DDC-treated mice. Neutrophil depletion or inhibition of recruitment was achieved using a Ly6g antibody or a CXCR1/2 inhibitor, respectively. Mice deficient in PAD4 (peptidyl arginine deiminase 4) and ELANE/NE (neutrophil elastase) were used to investigate the mechanisms underlying ductular reaction expansion. Results: In this study we describe a population of ductular reaction-associated neutrophils (DRANs), which are in direct contact with biliary epithelial cells in chronic liver diseases and whose numbers increased in parallel with disease progression. We show that DRANs are immobilized at the site of ductular reaction for a prolonged period of time. In addition, liver neutrophils display a unique phenotypic and transcriptomic profile, showing a decreased phagocytic capacity and increased oxidative burst. Depletion of neutrophils or inhibition of their recruitment reduces DRANs and the expansion of ductular reaction, while mitigating liver fibrosis and angiogenesis. Mechanistically, neutrophils deficient in PAD4 and ELANE abrogate neutrophil-induced biliary cell proliferation, thus indicating the role of neutrophil extracellular traps and elastase release in ductular reaction expansion. Conclusions: Overall, our study reveals the accumulation of DRANs as a hallmark of advanced liver disease and a potential therapeutic target to mitigate ductular reaction and the maladaptive wound-healing response. Impact and implications: Our results indicate that neutrophils are highly plastic and can have an extended lifespan. Moreover, we identify a new role of neutrophils as triggers of expansion of the biliary epithelium. Overall, the results of this study indicate that ductular reaction-associated neutrophils (or DRANs) are new players in the maladaptive tissue-healing response in chronic liver injury and may be a potential target for therapeutic interventions to reduce ductular reaction expansion and promote tissue repair in advanced liver disease., This work has been supported by grants from Fondo de Investigación Sanitaria Carlos III (FIS), co-financed by Fondo Europeo de Desarrollo Regional (FEDER), Unión Europea, “Una manera de hacer Europa” (FIS PI20/00765 to P.S.-B and FIS 18-PI18/00862 to M.C), from the NIH National Institute on Alcohol Abuse and Alcoholism grant 1U01AA021908-01-33490 to P.S.-B. P.G. is funded by Agencia de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) 2014 SGR 708, Centro de Investigación en Red Enfermedades Hepáticas y Digestivas (CIBERehd) and Institució Catalana de Recerca i Estudis Avançats (ICREA). MC is funded by Ramon y Cajal programme from the Ministerio de Ciencia e Innovación RYC2019-026662-I and by Plan estatal de investigación científica y técnica de innovación PID2021-125195OB-I00. S.A received a grant from the Ministerio de Educación, Cultura y Deporte, FPU programme (FPU17/04992). B.A.-B. is funded by Instituto de Salud Carlos III, PFIS (FI16/00203). SA funded by la Caixa Foundation (ID 100010434) and the European Union’s Horizon 2020 under the Marie Skłodowska-Curie (847648) and by the MCIN/AEI/10.13039/501100011033 by “FEDER Una manera de hacer Europa” (PID2021-124694OA-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Patient-derived liver organoids recapitulate liver epithelial heterogeneity and enable precision modeling of alcohol-related liver disease

  • Ariño, Silvia
  • Ferrer-Lorente, Raquel
  • Serrano, Guillermo
  • Zanatto, Laura
  • Martínez-García de la Torre, Raquel A.
  • Gratacós-Ginès, Jordi
  • Rubio, Ana Belén
  • Pérez, Martina
  • Mateos-Sánchez, Carlos
  • Aguilar-Bravo, Beatriz
  • Atkinson, Stephen
  • Xu, Zhengqing
  • Cantallops-Vilà, Paula
  • Sererols-Viñas, Laura
  • Ruiz-Blázquez, Paloma
  • Rill, Aina
  • Fundora, Yiliam
  • Lozano, Juan José
  • Coll, Mar
  • Ochoa, Idoia
  • Affo, Silvia
  • Moles, Anna
  • Mereu, Elisabetta
  • Bataller, Ramón
  • Pose, Elisa
  • Sancho-Bru, Pau
Animal models poorly recapitulate advanced alcohol-associated liver disease (ALD), precluding the development of new treatments. Organoids have emerged as a powerful human-based preclinical tool; however, current patient-derived liver organoids fail to capture epithelial heterogeneity and require surgical resections, limiting their use in personalized disease modeling. Here, we describe the development of organoids from liver needle biopsies (b-Orgs) obtained from patients with ALD., This work has been supported by grants to P.S-B. Proyecto PI20/00765 and PI23/00724, funded by “Instituto de Salud Carlos III (ISCIII) co-financed by the European Union. By HORIZON-HLTH-2022- STAYHLTH-02, grant number 101095679, funded by the European Union. Project FORT23/00002, funded by Instituto de Salud Carlos III (ISCIII) "Programa FORTALECE del Ministerio de Ciencia, Innovación y Universidades". This work has also been co-financed for P.S-B by the Spanish Ministry of Science and Innovation with funds from the European Union NextGenerationEU, from the Recovery, Transformation and Resilience Plan (PRTR-C17.I1) and from the Autonomous Community of Catalonia within the framework of the Biotechnology Plan Applied to Health (Q6922). S.A. received a fellowship from the Ministerio de Educación, Cultura y Deporte (FPU17/04992). R.A. M-G. was funded by the Instituto de Salud Carlos III, PFIS (FI18/00215). B.A-B. was funded by Instituto de Salud Carlos III, PFIS (FI16/00203). M.C. is funded by the Ramon y Cajal program from the Ministerio de Ciencia e Innovación RYC2019-026662-I and by the State Plan of Scientific and Technical Research and Innovation PID2021-125195OB-I00. S.A. is funded by the MCIN/AEI/10.13039/501100011033 by “ERDF A way of making Europe” (PID2021-124694OA-I00) and the European Union grant agreement 101077312. A.M. was funded by MCIN/AEI/10.13039/501100011033/FEDER, UE through the project grants PID2021-123652OB-I00 and RTI2018-097475-A-100; by MCIN/AEI/10.13039/501100011033; by Pfizer grant #77131383; and the contract RYC-2016-19731. P.R-B received a fellowship from the Spanish Ministry of Education, Culture and Sports, FPU program (FPU19/05357)., Peer reviewed